Stabilized tetrazolium phenazine reagent compositions and methods for using the same
    6.
    发明授权
    Stabilized tetrazolium phenazine reagent compositions and methods for using the same 有权
    稳定的四唑吩嗪试剂组合物及其使用方法

    公开(公告)号:US06939685B2

    公开(公告)日:2005-09-06

    申请号:US09988494

    申请日:2001-11-20

    CPC分类号: C12Q1/26 G01N33/52

    摘要: Stabilized tetrazolium dye-phenazine reagent compositions and methods for their use in the measurement of an analyte in a sample are provided. The subject reagent compositions include: (1) a tetrazolium dye component, e.g., a water soluble tetrazolium salt; (2) a phenazine component; and (3) an effective amount of one or more tetrazolium dye-phenazine stabilizing reagents, e.g., an inorganic Group IIIA compound and/or a flavin. In many embodiments, the subject reagent compositions include additional members of an analyte oxidizing signal producing system, such as: an analyte oxidizing enzyme, e.g., an analyte dehydrogenase or an analyte oxidase; and an enzyme cofactor. Also provided are test strips that include the subject reagent compositions, as well as systems and kits incorporating the subject test strips. The subject reagent compositions, test strips, systems and kits find use in the detection of a wide variety of analytes in a sample, such as a physiological sample, e.g., blood or a fraction thereof, or ISF (interstitial fluid).

    摘要翻译: 提供稳定的四唑染料 - 吩嗪试剂组合物及其用于测量样品中分析物的方法。 主题试剂组合物包括:(1)四唑鎓染料组分,例如水溶性四唑鎓盐; (2)吩嗪组分; 和(3)有效量的一种或多种四唑染料 - 吩嗪稳定试剂,例如无机IIIA族化合物和/或黄素。 在许多实施方案中,主题试剂组合物包括分析物氧化信号产生系统的附加成员,例如:分析物氧化酶,例如分析物脱氢酶或分析物氧化酶; 和酶辅因子。 还提供了包括主题试剂组合物的测试条,以及包含主题测试条的系统和试剂盒。 主题试剂组合物,测试条,系统和试剂盒可用于检测样品中各种分析物,例如生理样品,例如血液或其部分,或ISF(间质液)。

    PHOSPHORUS CONTAINING QUINAZOLINE COMPOUNDS AND METHODS OF USE
    8.
    发明申请
    PHOSPHORUS CONTAINING QUINAZOLINE COMPOUNDS AND METHODS OF USE 有权
    含有喹唑啉化合物的磷酸盐及其使用方法

    公开(公告)号:US20120196833A1

    公开(公告)日:2012-08-02

    申请号:US13380808

    申请日:2010-07-02

    摘要: Disclosed are novel quinazoline derivatives containing phosphorus substitutions and methods for the treatment of hyperproliferative diseases (e.g. cancer) using the compounds. These compounds are type I receptor protein kinase inhibitors useful in treating disorders related to abnormal protein kinase activities such as cancer and inflammation in mammals. Also disclosed are pharmaceutical compositions containing the compounds, methods for the preparation of the compounds and their pharmaceutically acceptable salts.

    摘要翻译: 公开了含磷取代的新型喹唑啉衍生物和使用该化合物治疗过度增殖性疾病(例如癌症)的方法。 这些化合物是I型受体蛋白激酶抑制剂,可用于治疗与异常蛋白激酶活性相关的疾病,例如哺乳动物的癌症和炎症。 还公开了含有化合物的药物组合物,制备化合物的方法及其药学上可接受的盐。

    8-(anilino)-1-naphthalenesulfonate analogs
    9.
    发明授权
    8-(anilino)-1-naphthalenesulfonate analogs 有权
    8-(苯胺基)-1-萘磺酸酯类似物

    公开(公告)号:US06218571B1

    公开(公告)日:2001-04-17

    申请号:US09428296

    申请日:1999-10-27

    IPC分类号: C07C30900

    摘要: 8-(anilino)-1-naphthalenesulfonate (ANS) analogs and methods for their use in analyte detection assays are provided. The subject ANS analogs are characterized by having at least one non-hydrogen substituent on their phenyl moiety and producing a reaction product with 3-methyl-2-benzothiazolinone hydrazone hydrchloride (MBTH) or an analog thereof, e.g. MBTHSB, that exhibits reduced drift. In certain preferred embodiments, the subject ANS analogs are described by the formula: wherein: n is 1 to 5; and X is a substituent other than H. The subject ANS analogs find use in a variety of applications, particularly in analyte detection assays, such as glucose detection assays.

    摘要翻译: 提供了8-(苯胺基)-1-萘磺酸盐(ANS)类似物及其在分析物检测测定中的应用。 主题ANS类似物的特征在于在其苯基部分上具有至少一个非氢取代基,并产生与3-甲基-2-苯并噻唑啉酮腙盐酸盐(MBTH)或其类似物的反应产物。 MBTHSB,减少漂移。 在某些优选实施方案中,主题ANS类似物由下式描述:其中:n为1至5; X是除H之外的取代基。主题ANS类似物可用于各种应用,特别是在分析物检测测定中,例如葡萄糖检测测定。